Coronavirus Disease 2019 (COVID-19): A Brief Report
Severe acute respiratory syndrome (“SARS-CoV-2”, previously provisionally named “2019 novel coronavirus” or “2019-nCoV”) disease (COVID-19) in China, at the end of 2019, resulted in a large global outbreak. Among patients with pneumonia caused by SARS-CoV-2, fever is the most common symptom, followe...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd
2020-04-01
|
Series: | Clinical Management Issues |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1467 |
_version_ | 1818851828541947904 |
---|---|
author | Domenico Lorenzo Urso |
author_facet | Domenico Lorenzo Urso |
author_sort | Domenico Lorenzo Urso |
collection | DOAJ |
description | Severe acute respiratory syndrome (“SARS-CoV-2”, previously provisionally named “2019 novel coronavirus” or “2019-nCoV”) disease (COVID-19) in China, at the end of 2019, resulted in a large global outbreak.
Among patients with pneumonia caused by SARS-CoV-2, fever is the most common symptom, followed by dry cough. Bilateral lung involvement with ground-glass opacities (GGOs) is the most common finding from computed tomography (CT) images of the chest.
At present, there are no specific antiviral drugs against SARS-CoV-2 infection for potential therapy of humans. Current treatments are mainly focused on symptomatic and respiratory support in patients with COVID-19. Preventive measures are the current strategy to limit the spread of cases.
The present report summarizes the point of the situation about this global emergency. |
first_indexed | 2024-12-19T07:11:14Z |
format | Article |
id | doaj.art-83f04dae399d4ca3a70971c68861e732 |
institution | Directory Open Access Journal |
issn | 2283-3137 |
language | English |
last_indexed | 2024-12-19T07:11:14Z |
publishDate | 2020-04-01 |
publisher | SEEd |
record_format | Article |
series | Clinical Management Issues |
spelling | doaj.art-83f04dae399d4ca3a70971c68861e7322022-12-21T20:31:11ZengSEEdClinical Management Issues2283-31372020-04-0114110.7175/cmi.v14i1.14671310Coronavirus Disease 2019 (COVID-19): A Brief ReportDomenico Lorenzo Urso0Emergency Department - Spoke Hospital Corigliano-Rossano (CS), ItalySevere acute respiratory syndrome (“SARS-CoV-2”, previously provisionally named “2019 novel coronavirus” or “2019-nCoV”) disease (COVID-19) in China, at the end of 2019, resulted in a large global outbreak. Among patients with pneumonia caused by SARS-CoV-2, fever is the most common symptom, followed by dry cough. Bilateral lung involvement with ground-glass opacities (GGOs) is the most common finding from computed tomography (CT) images of the chest. At present, there are no specific antiviral drugs against SARS-CoV-2 infection for potential therapy of humans. Current treatments are mainly focused on symptomatic and respiratory support in patients with COVID-19. Preventive measures are the current strategy to limit the spread of cases. The present report summarizes the point of the situation about this global emergency.https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1467sars-cov-2coronaviruspandemicpneumoniarespiratory support |
spellingShingle | Domenico Lorenzo Urso Coronavirus Disease 2019 (COVID-19): A Brief Report Clinical Management Issues sars-cov-2 coronavirus pandemic pneumonia respiratory support |
title | Coronavirus Disease 2019 (COVID-19): A Brief Report |
title_full | Coronavirus Disease 2019 (COVID-19): A Brief Report |
title_fullStr | Coronavirus Disease 2019 (COVID-19): A Brief Report |
title_full_unstemmed | Coronavirus Disease 2019 (COVID-19): A Brief Report |
title_short | Coronavirus Disease 2019 (COVID-19): A Brief Report |
title_sort | coronavirus disease 2019 covid 19 a brief report |
topic | sars-cov-2 coronavirus pandemic pneumonia respiratory support |
url | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1467 |
work_keys_str_mv | AT domenicolorenzourso coronavirusdisease2019covid19abriefreport |